Abstract:Studies on gene expression in response to therapy have led to the discovery of pharmacogenomics biomarkers and advances in precision medicine. Whole transcriptome sequencing (RNA-seq) is an emerging tool for profiling gene expression and has received wide adoption in the biomedical research community. However, its value in regulatory decision making requires rigorous assessment and consensus between various stakeholders, including the research community, regulatory agencies, and industry. The FDA-led SEquencing Quality Control (SEQC) consortium has made considerable progress in this direction, and is the subject of this review. Specifically, three RNA-seq platforms (Illumina HiSeq, Life Technologies SOLiD, and Roche 454) were extensively evaluated at multiple sites to assess cross-site and cross-platform reproducibility. The results demonstrated that relative gene expression measurements were consistently comparable across labs and platforms, but not so for the measurement of absolute expression levels. As part of the quality evaluation several studies were included to evaluate the utility of RNA-seq in clinical settings and safety assessment. The neuroblastoma study profiled tumor samples from 498 pediatric neuroblastoma patients by both microarray and RNA-seq. RNA-seq offers more utilities than microarray in determining the transcriptomic characteristics of cancer. However, RNA-seq and microarray-based models were comparable in clinical endpoint prediction, even when including additional features unique to RNA-seq beyond gene expression. The toxicogenomics study compared microarray and RNA-seq profiles of the liver samples from rats exposed to 27 different chemicals representing multiple toxicity modes of action. Cross-platform concordance was dependent on chemical treatment and transcript abundance. Though both RNA-seq and microarray are suitable for developing gene expression based predictive models with comparable prediction performance, RNA-seq offers advantages over microarray in profiling genes with low expression. The rat BodyMap study provided a comprehensive rat transcriptomic body map by performing RNA-Seq on 320 samples from 11 organs in either sex of juvenile, adolescent, adult and aged Fischer 344 rats. Lastly, the transferability study demonstrated that signature genes of predictive models are reciprocally transferable between microarray and RNA-seq data for model development using a comprehensive approach with two large clinical data sets. This result suggests continued usefulness of legacy microarray data in the coming RNA-seq era. In conclusion, the SEQC project enhances our understanding of RNA-seq and provides valuable guidelines for RNA-seq based clinical application and safety evaluation to advance precision medicine.

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

RNA-SeQC: RNA-seq metrics for quality control and process optimization

Comprehensive evaluation of differential expression analysis methods for RNA-seq data

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine

Precision and Accuracy of Single-Cell/Nuclei RNA Sequencing Data

Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data

RNA-QC-chain: Comprehensive and Fast Quality Control for RNA-Seq Data

RSeQC: quality control of RNA-seq experiments

GeneQC: A Quality Control Tool for Gene Expression Estimation Based on RNA-sequencing Reads Mapping

A New Machine Learning-Based Framework for Mapping Uncertainty Analysis in RNA-Seq Read Alignment and Gene Expression Estimation

IQSeq: Integrated Isoform Quantification Analysis Based on Next-Generation Sequencing.

Systematic assessment of long-read RNA-seq methods for transcript identification and quantification

Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences

RNASEQR—a Streamlined and Accurate RNA-seq Sequence Analysis Program

A Real-World Multi-Center RNA-seq Benchmarking Study Using the Quartet and MAQC Reference Materials

Impact of gene annotation choice on the quantification of RNA-seq data

Toward Best Practice in Identifying Subtle Differential Expression with RNA-seq: A Real-World Multi-Center Benchmarking Study Using Quartet and MAQC Reference Materials

Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis

mRNA enrichment protocols determine the quantification characteristics of external RNA spike-in controls in RNA-Seq studies

Molecular indexing enables quantitative targeted RNA sequencing and reveals poor efficiencies in standard library preparations

scRNABatchQC: multi-samples quality control for single cell RNA-seq data